Novo Holdings strengthens India focus with bigger investments in niche healthcare sectors
Hyderabad – Global investment powerhouse Novo Holdings is deepening its presence in India with major investments in single-specialty hospitals, advanced pharmaceutical manufacturing, and medical technology.
The move highlights India’s growing role as a global hub for healthcare innovation and patient-focused medical infrastructure.
Novo Holdings, which manages assets for the Novo Nordisk Foundation, is strategically expanding its portfolio across India to tap into high-growth healthcare opportunities.
With India emerging as one of the fastest-growing healthcare markets globally, the company aims to support hospitals and pharmaceutical manufacturers that deliver specialized, high-quality care to millions of patients.
The company has significantly increased its investment size, now ranging between $50 million and $125 million per project, compared to earlier deals averaging $20 million to $30 million.
Novo Holdings has also set up a dedicated investment team in Mumbai, reinforcing its long-term commitment to the Indian healthcare sector and its mission to improve access to advanced medical care.
According to company leaders, single-specialty hospitals are becoming the cornerstone of modern healthcare delivery in India. These specialized hospitals, focusing on areas such as oncology, maternity and child care, nephrology, and cardiology, offer patients more personalized and efficient treatments.
As demand grows for focused medical expertise, Novo Holdings plans to invest heavily in this segment, which is expected to reach $40 billion by 2032, according to industry research.
In addition to hospital investments, Novo Holdings is exploring partnerships with contract drug manufacturers in India. These companies play a crucial role in producing complex biological medicines used in the treatment of chronic illnesses such as cancer, diabetes, and autoimmune disorders.
By supporting these pharmaceutical innovators, Novo aims to strengthen India’s position as a leading hub for affordable and high-quality drug production.
The company is also looking into long-term investments in India’s emerging medical technology sector. With increasing innovation in diagnostics, digital health, and patient monitoring, medtech offers immense potential to revolutionize healthcare accessibility and efficiency.
Novo Holdings believes that India’s growing startup ecosystem and skilled talent pool make it an ideal location for future-focused healthcare investment.
Another area of focus is senior care and post-surgery recovery services, often referred to as step-down care. As India’s aging population grows and the demand for long-term patient support increases, these services will become vital to easing the pressure on large hospitals while ensuring continued recovery for patients outside intensive care units.
Experts view Novo Holdings’ strategy as a strong vote of confidence in India’s healthcare transformation. With an increasing focus on innovation, quality, and patient outcomes, India has become an attractive destination for global healthcare investors.
Novo’s investment will likely accelerate improvements in infrastructure, create more skilled healthcare jobs, and enhance medical access across urban and rural regions alike.
The company’s approach reflects a broader global trend of investing in sustainable and patient-centric healthcare systems. By combining financial strength with deep industry expertise, Novo Holdings aims to help India shape the future of healthcare — one that is specialized, accessible, and innovation-driven.
